Sage Rhino Capital’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118K Buy
25,447
+394
+2% +$2.06K 0.02% 320
2025
Q4
$125K Buy
25,053
+794
+3% +$4.13K 0.02% 302
2025
Q3
$123K Sell
24,259
-1,111
-4% -$4.89K 0.02% 289
2025
Q2
$109K Sell
25,370
-2,453
-9% -$12.1K 0.02% 266
2025
Q1
$168K Buy
27,823
+5,524
+25% +$27.9K 0.04% 243
2024
Q4
$88.1K Sell
22,299
-10,158
-31% -$45.5K 0.02% 263
2024
Q3
$190K Sell
32,457
-2,564
-7% -$12.6K 0.04% 251
2024
Q2
$151K Buy
35,021
+7,720
+28% +$37K 0.04% 227
2024
Q1
$128K Buy
+27,301
New +$105K 0.03% 220

Other funds holding MPT

Sage Rhino Capital's MPT Position: Q1 2026 in Review

Sage Rhino Capital increased its Medical Properties Trust (MPT) stake by 1.6% in Q1 2026, buying an estimated $2.06K and bringing the position to 25,447 shares worth $118K. The position accounts for 0.02% of the portfolio, ranked #320.

Sage Rhino Capital first reported a position in MPT in Q1 2024 and has held it in 9 quarters since. The position peaked at $190K in Q3 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Sage Rhino Capital held 25,447 shares of Medical Properties Trust worth $118K as of Q1 2026.
  • Sage Rhino Capital bought 394 Medical Properties Trust shares in Q1 2026, an estimated $2.06K.
  • Medical Properties Trust made up 0.02% of Sage Rhino Capital's portfolio in Q1 2026, its #320 holding.
  • Sage Rhino Capital first reported a position in Medical Properties Trust in Q1 2024 and has held it in 9 quarters since.
  • Sage Rhino Capital's Medical Properties Trust position peaked at $190K in Q3 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Sage Rhino Capital's 13F filing for Q1 2026, filed 28 Apr 2026.